Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for COVID-19.
Read full Post
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment